Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
肝芳基烃受体对肥胖的调节:作用机制
基本信息
- 批准号:10701901
- 负责人:
- 金额:$ 35.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-09 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:ARNT geneARNTL geneAffectArchitectureAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorBinding SitesBiologicalBrainBrown FatCell LineCell SeparationCellsChemicalsChromatinCircadian RhythmsCuesDepositionDevelopmentDioxinsDisparateElectron TransportEnvironmental PollutantsEstrogensEventExhibitsExposure toFGF21 geneFemaleGene ExpressionGeneral PopulationGenesGenomicsGlucagonGlucocorticoidsGonadal Steroid HormonesHealthHepaticHepatocyteHigh Fat DietHomeostasisHumanInsulinInterventionKnockout MiceLigandsLiverMediatingMetabolicMetabolic DiseasesMetabolic hormoneMitochondriaMolecularMusMuscleMutateObesityOutcomePathway interactionsPeriodicityPhasePhenotypePhysiologicalPhysiological ProcessesProcessPropertyProtein FamilyProteinsReceptor SignalingRegulationReportingResearchRespirationResponse ElementsRiskSignal TransductionSomatotropinStat5 proteinSuggestionTertiary Protein StructureTestingTetrachlorodibenzodioxinTherapeuticThermogenesisThyroid HormonesTranscriptional RegulationTransfectionVariantXenobioticscarbohydrate metabolismcircadianclinical developmentcombatconditional knockoutdiet-induced obesityestrogenicfibroblast growth factor 21hepatoma cellimprovedin vivolipid metabolismmembernovel strategiespollutantpreservationprime editingpromoterreceptor expressionreconstitutionresponsesexual dimorphismsingle-cell RNA sequencingsingle-minded proteinsuccesstranscription factortranscriptometranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT
The Aryl Hydrocarbon Receptor (AhR) is a member of the eukaryotic Per-ARNT-Sim (PAS) domain protein
family that regulates adaptive and toxic responses to a variety of chemical pollutants, including polycyclic
aromatic hydrocarbons and polychlorinated dioxins, most notably 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
We recently showed that female, but not male liver-specific AhR conditional knockout mice are protected from
high fat diet-induced obesity and exhibited improved metabolic homeostasis. The sexually dimorphic
phenotype was attributed to increased hepatic expression of fibroblast growth factor 21 (FGF21) in females.
FGF21 is a circulating hepatokine that affects carbohydrate and lipid metabolism, and induces thermogenesis
in white and brown fat deposits by uncoupling mitochondrial respiration from the electron transport chain.
These properties have motivated research into the development of FGF21-based therapeutics to combat
metabolic disorders and obesity, but with little success to date. Hence, understanding how AhR activity
controls Fgf21 expression may point to novel strategies or targets for the development of clinical interventions.
Hepatic Fgf21 expression is also under the control of sex steroids and is subject to circadian rhythms. The
latter observation is of note because both the AhR and its partner protein, the AhR Nuclear Translocator
(ARNT), belong to the same PAS protein family as several of the circadian rhythm (clock) proteins, including
brain and muscle ARNT-like 1 (BMAL1). Hepatic AhR expression exhibits a 24 h periodicity in phase with
BMAL1 oscillations, suggestive of co-regulation of these proteins. Moreover, ARNT shares considerable
sequence similarity to BMAL1, and an AhR-BMAL1 interaction has been reported, implying that interactions
between circadian rhythmicity and AhR signaling are reciprocal and significant. The central premise of this
application is, that hepatic Fgf21 expression represents a nexus where AhR signaling and the molecular events
underlying sexual dimorphism and circadian rhythmicity, coalesce. We hypothesize that a comprehensive
assessment of how these physiologically disparate signaling processes are integrated is required to fully
understand AhR regulated Fgf21 expression, and its impact on diet-induced obesity. To test the hypothesis,
we propose experimental strategies that preserve the physiological context and genomic milieu. Specific Aim 1
will examine Fgf21 promoter functionality from the standpoint of AhR, ARNT, and BMAL1 activity as a function
of circadian rhythmicity. Specific Aim 2 will use single-cell transcriptomics to identify diurnal changes in liver
gene expression due to AhR, ARNT, and BMAL1 activity. Specific Aim 3 will interrogate sexually dimorphic
Fgf21 expression as a function of estrogenicity. The Specific Aims constitute distinct yet integrated endeavors
to mechanistically understand how the AhR regulates Fgf21 expression in the liver, under experimental
conditions that preserve the physiological processes responsible for the sexual dimorphism and circadian
rhythmicity in the context of a native genomic milieu that retains normal chromatin architecture.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cornelis Johan Elferink其他文献
Cornelis Johan Elferink的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cornelis Johan Elferink', 18)}}的其他基金
Gulf Coast Center for Precision Environmental Health
墨西哥湾沿岸精准环境健康中心
- 批准号:
10647883 - 财政年份:2019
- 资助金额:
$ 35.62万 - 项目类别:
Gulf Coast Center for Precision Environmental Health
墨西哥湾沿岸精准环境健康中心
- 批准号:
10390320 - 财政年份:2019
- 资助金额:
$ 35.62万 - 项目类别:
Administrative Supplement for Gulf Coast Center for Precision Environmental Health
墨西哥湾沿岸精准环境健康中心行政补充
- 批准号:
10436634 - 财政年份:2019
- 资助金额:
$ 35.62万 - 项目类别:
Aryl Hydrocarbon Receptor-Mediated Epigenetic Processes
芳基烃受体介导的表观遗传过程
- 批准号:
9124375 - 财政年份:2016
- 资助金额:
$ 35.62万 - 项目类别:
A Novel Paradigm for Aryl Hydrocarbon Receptor Signaling
芳基烃受体信号传导的新范例
- 批准号:
8896257 - 财政年份:2015
- 资助金额:
$ 35.62万 - 项目类别:
Gulf Coast Health Alliance: health Risks related to the Macondo Spill (GC-HARMS)
墨西哥湾沿岸健康联盟:与马孔多泄漏事件相关的健康风险 (GC-HARMS)
- 批准号:
8469037 - 财政年份:2011
- 资助金额:
$ 35.62万 - 项目类别:
Gulf Coast Health Alliance: health Risks related to the Macondo Spill (GC-HARMS)
墨西哥湾沿岸健康联盟:与马孔多泄漏事件相关的健康风险 (GC-HARMS)
- 批准号:
8727814 - 财政年份:2011
- 资助金额:
$ 35.62万 - 项目类别:
Gulf Coast Health Alliance: health Risks related to the Macondo Spill (GC-HARMS)
墨西哥湾沿岸健康联盟:与马孔多泄漏事件相关的健康风险 (GC-HARMS)
- 批准号:
8213830 - 财政年份:2011
- 资助金额:
$ 35.62万 - 项目类别:














{{item.name}}会员




